StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

AKYABearishEarningsnews
Materiality pending

Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates

May 13, 2024, 6:47 PM EDT1 sourcesAI-analyzed

AI summary

What happened, with direct paths to the underlying reporting

- Akoya Biosciences reported $0.35 loss per share, missing estimates by 16.67%. - Revenues for Akoya were $18.35 million, below estimates by 23.94%. - Akoya shares have decreased by 12.6% this year compared to S&P 500's gain of 9.5%. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings

  • Akoya Biosciences reported $0.35 loss per share, missing estimates by 16.67%.
  • Revenues for Akoya were $18.35 million, below estimates by 23.94%.
  • Akoya shares have decreased by 12.6% this year compared to S&P 500's gain of 9.5%.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.